Report Overview
Europe Infusion Pumps Market reached US$ 547.05 million in 2023 and is expected to reach US$ 890 million by 2031, growing at a CAGR of 6.4% during the forecast period 2024-2031.
Infusion pumps are utilized extensively in the home and clinical environments such as nursing homes and hospitals. In contrast to manual administration, they provide numerous benefits, including the ability to administer fluids in minute quantities and at precisely programmed or automated intervals.
They are utilized to administer medications or nutrients, including antibiotics, insulin or other hormones, painkillers, and chemotherapy medicines. Patient-controlled analgesia, syringes, insulin pumps, and elastomeric infusion pumps are all examples of infusion pumps.
Market Scope
| Metrics | Details |
| CAGR | 6.4% |
| Market Size Available for Years | 2022-2031 |
| Estimation Forecast Period | 2024-2031 |
| Revenue Units | Value (US$ Mn) |
| Segments Covered | Product Type, Application, End-User |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights. |
For more details on this report – Request for Sample
Market Dynamics: Drivers & Restraints
Rising prevalence of chronic diseases
The most frequent chronic illnesses in many communities are cardiovascular disease, diabetes, and cancer. For instance, according to the report by the World Health Organization in 2024, it is stated that cardiovascular diseases (CVDs) are the predominant cause of disability and premature death in the European Region, causing over 42.5% of all deaths annually. For diabetes, healthcare personnel utilize infusion pumps to maintain constant glucose levels while giving the medicine to the patient without errors.
Infusion pumps are also employed in the treatment of cancer patients who need ongoing chemotherapy to prevent cancer or abnormal cell development in the body. A regulated number of medications should be delivered to the circulation throughout the chemotherapy procedure, which may be accomplished via infusion pumps. The rising number of cancer patients is also expected to drive the market growth in the region.
Regulatory challenges
Regulatory challenges associated with approving infusion pumps are expected to hinder the market's growth. To meet the required regulatory standards companies face financial burden. These can include costs associated with clinical studies, documentation, quality control methods, and GMP compliance, which can be expensive for smaller companies or startups.
Market Segment Analysis
The Europe infusion pumps market is segmented based on product type, application, and end-user.
Insulin infusion pumps segment is expected to dominate the market share
Insulin infusion pumps segment holds a significant portion of the market share and is expected to continue throughout the forecast period. This is due to the increasing adoption of these pumps by diabetic patients with the increasing diabetic population in the region. The growing diabetes population is one of the major concerns which increases the need for insulin infusions.
Diabetes is one of the most common chronic conditions in the WHO European Region, and Europe has the highest burden of type 1 diabetes in the world. A report by WHO stated that it is estimated that 1 in 10 people living in the Region will have diabetes by 2045. According to the European Union, it is stated that over 33 million people in the EU suffer from diabetes.
Insulin infusion pumps offer patients a more comfortable treatment experience by providing a steady and controlled delivery of insulin. This eliminates the need for frequent manual interventions, reducing discomfort and anxiety associated with treatment administration. Thus, the above factors are expected to drive the segment growth during the forecast period.
Market Segmentation
By Product Type
- Implantable Infusion Pumps
- Insulin Infusion Pumps
- Syringe Infusion Pumps
- Volumetric Infusion Pumps
- Others
By Application
- Diabetes
- Chemotherapy/Oncology
- Gastroenterology
- Analgesia/Pain Management
- Pediatrics/Neonatology
- Hematology
- Others
By End-User
- Hospitals & Clinics
- Ambulatory Care Settings
- Home Care Settings
- Academic & Research Institutes
- Others
Market Competitive Landscape
The major players in the market include B. Braun Melsungen AG, Fresenius Kabi AG, ICU Medical, Inc., Smiths Group PLC, Medtronic Plc, Terumo Europe NV, Nipro Medical Europe N.V., UAB Viltechmeda, Arcomed NV and Emsere BV among others.
Why Purchase the Report?
- To visualize the Europe infusion pumps market segmentation based on product type, application, and end-user, as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of infusion pumps market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as Excel consisting of key products of all the major players.
The Europe infusion pumps market report would provide approximately 53 tables, 47 figures, and 176 pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
